Pulmonary Hypertension
Pulmonary Hypertension is a condition characterized by high blood pressure in the arteries leading from the heart to the lungs, forcing the heart to work harder and causing symptoms such as shortness of breath, chest pain, fatigue, and a fast heartbeat. It is diagnosed when the pulmonary mean arterial pressure exceeds 20mmHg at rest and pulmonary vascular resistance is greater than 3 Wood units.
Health Outcomes
- Decreased Lower Respiratory Quotient
- Decreased Oxygen Saturation
- Decreased Oxygenated Hemoglobin Level
- Enhanced Nitric Oxide Production
- Improved 6-Minute Walk Test Distance
- Improved 6-minute Walking Distance
- Improved Ang-(1-7)/Ang II Ratio
- Improved Arterial Oxygen Partial Pressure
- Improved Arterial Oxygen Saturation
- Improved Blood Vessel Growth
- Improved Breath Perception
- Improved Cardiopulmonary Exercise Testing
- Improved Constant Work Rate Exercise Time
- Improved Dyspnea
- Improved Exercise Capacity
- Improved Exercise Function
- Improved Exercise Tolerance
- Improved Fractional Shortening
- Improved Hemodynamic Parameter
- Improved Hemodynamic Stability
- Improved Hypoxia Resistance
- Improved Limited Distance Test Performance
- Improved Maximal Oxygen Capacity
- Improved Maximal Oxygen Consumption
- Improved Oxygen Saturation
- Improved Oxygenation Index
- Improved Peak Oxygen Intake
- Improved Right Ventricular Function
- Improved Six Minute Walking Distance
- Improved Six-Minute Walk Distance
- Improved Six-Minute Walk Test
- Improved Stroke Volume
- Improved VO2max
- Improved Vasodilation
- Increased 6-Minute Walk Test Distance
- Increased Caveolin-1 Level
- Increased Deoxygenated Hemoglobin Level
- Increased Endothelial Progenitor Cell Count
- Increased Erythropoietin Level
- Increased Exercise Capacity
- Increased Hemodynamic Disturbance
- Increased L-Arginine to ADMA Ratio
- Increased Nitric Oxide Bioavailability
- Increased Nitric Oxide Metabolite Level
- Increased Nitric Oxide Production
- Increased Peak Oxygen Uptake
- Increased Plasma Nitric Oxide Levels
- Increased Survival in High Osmotic Pressure
- Increased TGFB1 Level
- Increased TIMP-1 Levels
- Increased Type 1 Collagen Synthesis
- Modulated Arterial Diameter
- Modulated Pulmonary Innate Immune Microenvironment
- Preserved Cardiac Function
- Reduced Apelin Gene Expression
- Reduced Apoptosis
- Reduced Arginine Level
- Reduced Borg Scale Score
- Reduced Cardiac Output
- Reduced Deoxygenated Hemoglobin Level
- Reduced Dyspnea
- Reduced Exertional Dyspnea
- Reduced Lung Damage
- Reduced Nitric Oxide Production
- Reduced Oxygen Consumption during Exercise
- Reduced Oxygen Saturation Decrease
- Reduced Prostaglandin E2 Level
- Reduced Pulmonary Artery Systolic Pressure
- Reduced Shortness of Breath
- Reduced Stroke Volume
- Reduced Thrombosis
- Reduced Tricuspid Regurgitation
- Reduced Vascular Endothelial Growth Factor Level